文献速递贫血与红细胞疾病白血病

MECOM基因新突变在体外影响MPL调控并导致血小板减少和骨髓衰竭

A novel mutation in MECOM affects MPL regulation in vitro and results in thrombocytopenia and bone marrow failure.
PubMed 文献 · Br J Haematol · 2023-08-23

MECOM相关综合征以无巨核细胞性血小板减少、进行性骨髓衰竭、全血细胞减少和桡尺骨融合为特征,由MECOM基因(编码转录因子EVI1)突变所致。研究在一名严重血小板减少的儿科患者中发现MECOM新变异p.P634L,体外实验显示该突变损害转录因子的抑制活性,并证明EVI1调控MPL的转录,可能解释MECOM-AS与先天性无巨核细胞性血小板减少症(CAMT)的部分重叠。

要点

  • MECOM-AS表现为无巨核细胞性血小板减少、骨髓衰竭、全血细胞减少和桡尺骨融合,常在新生儿期诊断。
  • 在儿科患者中鉴定出MECOM新变异p.P634L,体外显示其损害EVI1的抑制活性。
  • EVI1调控MPL转录,可能解释MECOM-AS与CAMT的部分表型重叠。

核心结论

  • MECOM新变异p.P634L损害EVI1转录抑制活性,EVI1调控MPL转录,可能解释MECOM-AS与CAMT的部分重叠。

研究设计与样本

  • 在1名严重血小板减少的儿科患者中鉴定MECOM基因新变异p.P634L,并在体外检测该突变对pAP-1增强子元件和靶基因启动子的影响。

主要发现

  • 患者携带MECOM基因新变异p.P634L。
  • 体外实验显示p.P634L突变损害EVI1转录因子的抑制活性。
  • EVI1调控MPL的转录,MPL突变是先天性无巨核细胞性血小板减少症(CAMT)的病因。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

MECOM-associated syndrome (MECOM-AS) is a rare disease characterized by amegakaryocytic thrombocytopenia, progressive bone marrow failure, pancytopenia and radioulnar synostosis with high penetrance. The clinical phenotype may also include finger malformations, cardiac and renal alterations, hearing loss, B-cell deficiency and predisposition to infections. The syndrome, usually diagnosed in the neonatal period because of severe thrombocytopenia, is caused by mutations in the MECOM gene, encoding for the transcription factor EVI1. The mechanism linking the alteration of EVI1 function and thrombocytopenia is poorly understood. In a paediatric patient affected by severe thrombocytopenia, we identified a novel variant of the MECOM gene (p.P634L), whose effect was tested on pAP-1 enhancer element and promoters of targeted genes showing that the mutation impairs the repressive activity of the transcription factor. Moreover, we demonstrated that EVI1 controls the transcriptional regulation of MPL, a gene whose mutations are responsible for congenital amegakaryocytic thrombocytopenia (CAMT), potentially explaining the partial overlap between MECOM-AS and CAMT.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Ammeti D, Marzollo A, Gabelli M, et al. A novel mutation in MECOM affects MPL regulation in vitro and results in thrombocytopenia and bone marrow failure. Br J Haematol. 2023. PMID: 37610030. doi:10.1111/bjh.19023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。